Pristine Pearl Pharma Private Limited

Pristine Pearl Pharma Private Limited - pharma in Ukkadam, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74110TZ2014PTC021000 Incorporated 29 December 2014 ROC Coimbatore HQ Ukkadam, Tamil Nadu, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹68.51 Cr
▼ 6% YoY
Net profit · FY 2025
₹57.48 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹2.8 Cr
EBITDA margin 4.1%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹34 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
409
Provident fund records

About Pristine Pearl Pharma Private Limited

Data last updated:

Pristine Pearl Pharma Private Limited is a private limited company based in Ukkadam, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74110TZ2014PTC021000. Its GSTIN is 33AAGCB2183C1Z6 (Tamil Nadu). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Pearl Labs(India) Private Limited and Pearl Laboratory Private Limited. It is led by directors including Mohamedayoob and Ummalhaseena.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at ''Palepu Palladium'' 1st Floor Kempetty Colony Selvapuram By Pass Road, Ukkadam, Tamil Nadu, India – 641001.

As per the financials filed for FY 2025, the company reported a revenue of ₹68.51 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹57.48 Lakh (net margin 0.8%) and EBITDA of ₹2.8 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 53% over five years.

The company has about 409 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹34 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.

Pristine Pearl Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0040080). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pristinepearl.com.

Company details

CIN U74110TZ2014PTC021000
Registration Number 021000
Incorporation Date 29 December 2014
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-03-0040080

Name history

Pristine Pearl Pharma has undergone 3 name changes throughout its history. The company was previously known as Pearl Labs(India) Private Limited, Pearl Laboratory Private Limited, and Best Multispeciality Hospitals India Private Limited. The current legal name is Pristine Pearl Pharma Private Limited.

Company NameStatus
Pristine Pearl Pharma Private LimitedCurrent
Pearl Labs(India) Private LimitedPrevious
Pearl Laboratory Private LimitedPrevious
Best Multispeciality Hospitals India Private LimitedPrevious

CIN history

Pristine Pearl Pharma has one previous CIN (Corporate Identification Number): U85191TZ2014PTC021000. The current CIN is U74110TZ2014PTC021000, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74110TZ2014PTC021000Current
U85191TZ2014PTC021000Previous

Recognitions & Rankings of Pristine Pearl Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-TN-03-0040080

Contact details

Pristine Pearl Pharma Private Limited's registered office is in Ukkadam, Tamil Nadu. Its website is pristinepearl.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    ''Palepu Palladium'' 1st Floor Kempetty Colony Selvapuram By Pass Road, Ukkadam, Tamil Nadu, India – 641001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Pristine Pearl Pharma Private Limited, buy the company report.

Comprehensive company report
Pristine Pearl Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pristine Pearl Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Pristine Pearl Pharma Private Limited, buy the company report.

Financials of Pristine Pearl Pharma Private Limited

FY 2025 filings available

Pristine Pearl Pharma Private Limited reported revenue of ₹68.51 Cr (down 6% YoY) for FY 2025.

Revenue · FY 2025
₹68.51 Cr ▼ 6%
Net profit · FY 2025
₹57.48 Lakh margin 0.8%
EBITDA · FY 2025
₹2.8 Cr margin 4.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 38%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 70%
5 years · compounded
▲ 93%

Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 53%. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.8 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹57.48 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.1%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pristine Pearl Pharma Private Limited, buy the company report.

Board of directors of Pristine Pearl Pharma Private Limited

Pristine Pearl Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
UmmalhaseenaAdditional Director25 Apr 20188 Years 6 MonthsCurrent
Mohammedsirajudeen AashikahmedAdditional Director25 Apr 20188 Years 6 MonthsCurrent
MohamedayoobDirector29 Dec 201411 Years 10 MonthsCurrent

Peer comparison

Pristine Pearl Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zelleven Lifescience Private Limited₹69.02 Cr (FY 2025)12.0%New Delhi, Delhi, India
Vama Lifecare Private Limited₹68.87 Cr (FY 2024)16.0%Mumbai, Maharashtra, India
Pristine Pearl Pharma Private Limitedthis company₹68.51 Cr (FY 2025)₹57.48 Lakh0.8%-6.0%409Ukkadam, Tamil Nadu, India
Iberia Pharmaceuticals India Limited₹67.39 Cr (FY 2023)54.0%New Delhi, Delhi, India

To see the full peer comparison of Pristine Pearl Pharma Private Limited, buy the company report.

Auditor

Pristine Pearl Pharma Private Limited is audited by SHANMUGAM VASUDEVAN AND COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SHANMUGAM VASUDEVAN AND COMPANYFY 2023011627S

Shareholding

The shareholding of Pristine Pearl Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pristine Pearl Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹25 Cr
Satisfied charges
₹34 Cr
Breakdown by lending institutions
Others₹25.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 May 2025101108496Others₹25 CrOpen
29 Apr 2024100921018Others₹19 CrSatisfied
24 Dec 2021100528531Hdfc Bank Limited₹15 CrSatisfied

To see the full charge records of Pristine Pearl Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pristine Pearl Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Pristine Pearl Pharma Private Limited has a workforce of 409 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
409
Active EPFO establishments
1
Employee growth
-1.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27409
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Pristine Pearl Pharma Private Limited, buy the company report.

GST

Pristine Pearl Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AAGCB2183C1Z6Tamil NaduActive01 Jul 2017
29AAGCB2183C1ZVKarnatakaActive12 Sep 2022

To see the full GST registrations and return filing status of Pristine Pearl Pharma Private Limited, buy the company report.

Recent activity

Pristine Pearl Pharma Private Limited has 7 board changes on record since 2014: 3 appointments and 4 cessations. The latest: Abdul Rahman Mujibur Rahman ceased to be Additional Director on 17 Oct 2022.

AGM
Pristine Pearl Pharma Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
A charge registered on 29 Apr 2024 via Charge ID 100921018 with Others was fully satisfied on 18 Jun 2025.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101108496 was registered on 05 May 2025.
Filing
Pristine Pearl Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore.
Charges
A charge registered on 24 Dec 2021 via Charge ID 100528531 with Hdfc Bank Limited was fully satisfied on 14 Nov 2024.
Charges
A charge with Others amounted to Rs. 19.00 Cr with Charge ID 100921018 was registered on 29 Apr 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 15.00 Cr registered on 24 Dec 2021 with Charge ID 100528531 was modified on 21 Oct 2023.
Ceased
Abdul Rahman Mujibur Rahman ceased to be Additional Director.
Ceased
Kaliappan Uthayamoorthi ceased to be Additional Director.
Ceased
Muthumanikandan Muthu ceased to be Director.
Ceased
Uma Thanigai Vassan ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100528531 was registered on 24 Dec 2021.

4 earlier events are in the company report.

Frequently asked questions

Pristine Pearl Pharma is an active private limited company based in Ukkadam, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2014 (12+ years old) and is registered under CIN U74110TZ2014PTC021000.

Pristine Pearl Pharma has 3 current directors:

The latest financial statements of Pristine Pearl Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Pristine Pearl Pharma is 33AAGCB2183C1Z6, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAGCB2183C1ZV (Karnataka).

The CIN (Corporate Identification Number) of Pristine Pearl Pharma is U74110TZ2014PTC021000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pristine Pearl Pharma has 3 court cases on record: 3 filed against it. 3 are pending.

Pristine Pearl Pharma was incorporated on 29 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Coimbatore.

The peers of Pristine Pearl Pharma by revenue are Zelleven Lifescience Private Limited, Vama Lifecare Private Limited, Iberia Pharmaceuticals India Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Abdul Rahman Mujibur Rahman ceased to be Additional Director on 17 Oct 2022. Kaliappan Uthayamoorthi ceased to be Additional Director on 17 Oct 2022. Muthumanikandan Muthu ceased to be Director on 17 Oct 2022. Pristine Pearl Pharma has 7 board changes on record in total.

Yes, Pristine Pearl Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-03-0040080).

Pristine Pearl Pharma can be reached through the website pristinepearl.com. Its registered office is in Ukkadam, Tamil Nadu, India.